HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Long-term analysis of combined liver and kidney transplantation at a single center.

AbstractOBJECTIVE:
To analyze use of combined liver and kidney transplantation (CLKT) for patients with chronic primary diseases of both organs and for patients with hepatorenal syndrome.
DESIGN:
Retrospective case series.
SETTING:
Multiorgan transplantation service in a large university medical center.
PATIENTS:
A total of 98 patients underwent 99 CLKTs during a 16-year period; 76 had primary renal diseases, and 22 had hepatorenal syndrome. Patients receiving isolated liver and kidney transplants were analyzed for comparison.
MAIN OUTCOME MEASURES:
Patient and graft survival, rejection rates, and need for hemodialysis before and after transplantation.
RESULTS:
Overall patient survival was 76%, 72%, and 70% at 1, 3, and 5 years, respectively; liver graft survival was 70%, 65%, and 65%; and kidney graft survival was 76%, 72%, and 70%. No risk factors analyzed for recipients or donors were associated significantly with early posttransplantation mortality or graft loss. In 28 patients who received monoclonal antibody induction therapy with interleukin 2 blockers, there were significantly fewer episodes of acute liver rejection. For patients with hepatorenal syndrome, CLKT did not confer a survival advantage over liver-only transplantation (1-year patient survival was 72% vs 66%; P = .88). The 1-year acute kidney rejection rate in the adult CLKT group was 14% vs 23% in a 5-year cadaveric renal transplantation cohort (P<.01).
CONCLUSIONS:
First, CLKT is indicated in patients with dual organ disease and achieves excellent results. Second, CLKT for hepatorenal syndrome is indicated in patients receiving hemodialysis for longer than 8 weeks and confers advantages in patient survival and use of hospital resources. Third, the liver is immunoprotective for the kidney.
AuthorsRichard Ruiz, Hiroko Kunitake, Alan H Wilkinson, Gabriel M Danovitch, Douglas G Farmer, Rafik M Ghobrial, Hasan Yersiz, Jonathan R Hiatt, Ronald W Busuttil
JournalArchives of surgery (Chicago, Ill. : 1960) (Arch Surg) Vol. 141 Issue 8 Pg. 735-41; discussion 741-2 (Aug 2006) ISSN: 0004-0010 [Print] United States
PMID16924080 (Publication Type: Comparative Study, Journal Article)
Topics
  • Adolescent
  • Adult
  • Aged
  • Child
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Graft Rejection (epidemiology)
  • Graft Survival
  • Hepatorenal Syndrome (mortality, surgery)
  • Humans
  • Incidence
  • Infant
  • Kidney Transplantation (methods, mortality)
  • Liver Transplantation (methods, mortality)
  • Male
  • Middle Aged
  • Retrospective Studies
  • Risk Factors
  • Survival Rate (trends)
  • Time Factors
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: